<p>White boxes represent the subset of subjects with genotypes available from both blood and genital secretions. The ‘untreated’ group refers to subjects who were either antiretroviral drug naïve or who had been off ART for ≥90 days.</p
<p>Flow chart of individuals newly diagnosed at the CMSDS, who experienced at least one missed oppor...
<p>Subjects positive for HBsAg and/or HBV-DNA were considered carriers of HBV. Subjects positive for...
<p>The figure provides an overview of the study cohort, including the number of samples tested and t...
<p>Vertical bars represent percent of subjects with detectable viral load at study enrollment by ana...
<p>Flowchart of HIV-infected patients who entered the study, and the proportion who developed tuberc...
<p>Flow chart depicting status of HIV infected individuals who were put on ART at the end of study p...
<p>Flow chart of patients recruited to the study stratified by patient subgroup, smear microscopy, H...
<p>Flowchart showing the inclusion of study participants (FGS = female genital schistosomiasis, CVL...
Distribution of individuals included in the survey by HIV status, country, ART eligibility at the ti...
Flow chart showing distribution of HIV infected individuals captured in the national data warehouse ...
<p>This flow chart provides information on the number of patients recruited, eligible for antiretrov...
Flow chart showing enrollment of study participants, viral load and genotypic testing.</p
<p><b>Total specimens = 184. At least one act of penile-vaginal sex had to be unprotected (no condom...
<p>Flowchart of inclusion in the different stages of the study, and patient's prevalence of anti-HCV...
<p>Flow diagram of patient participants in a group-randomized trial of prevention with people living...
<p>Flow chart of individuals newly diagnosed at the CMSDS, who experienced at least one missed oppor...
<p>Subjects positive for HBsAg and/or HBV-DNA were considered carriers of HBV. Subjects positive for...
<p>The figure provides an overview of the study cohort, including the number of samples tested and t...
<p>Vertical bars represent percent of subjects with detectable viral load at study enrollment by ana...
<p>Flowchart of HIV-infected patients who entered the study, and the proportion who developed tuberc...
<p>Flow chart depicting status of HIV infected individuals who were put on ART at the end of study p...
<p>Flow chart of patients recruited to the study stratified by patient subgroup, smear microscopy, H...
<p>Flowchart showing the inclusion of study participants (FGS = female genital schistosomiasis, CVL...
Distribution of individuals included in the survey by HIV status, country, ART eligibility at the ti...
Flow chart showing distribution of HIV infected individuals captured in the national data warehouse ...
<p>This flow chart provides information on the number of patients recruited, eligible for antiretrov...
Flow chart showing enrollment of study participants, viral load and genotypic testing.</p
<p><b>Total specimens = 184. At least one act of penile-vaginal sex had to be unprotected (no condom...
<p>Flowchart of inclusion in the different stages of the study, and patient's prevalence of anti-HCV...
<p>Flow diagram of patient participants in a group-randomized trial of prevention with people living...
<p>Flow chart of individuals newly diagnosed at the CMSDS, who experienced at least one missed oppor...
<p>Subjects positive for HBsAg and/or HBV-DNA were considered carriers of HBV. Subjects positive for...
<p>The figure provides an overview of the study cohort, including the number of samples tested and t...